Clinical Trial Update: Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on using metformin in older patients with heart failure with preserved ejection fraction; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 2 | Status: ACTIVE_NOT_RECRUITING